Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niru B Soni

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Biomolecular Screening|March 10, 2004
A strategy for discovery of novel broad-spectrum antibacterials using a high-throughput Streptococcus pneumoniae transcription/translation screenSteven D Pratt, Caroline A David, Candace Black-Schaefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2011
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitorXuesong Liu, Yan Shi, David X Maag, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2012
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase familiesMichael L Curtin, Robin R Frey, H Robin Heyman, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Thienopyridine urea inhibitors of KDR kinaseH Robin Heyman, Robin R Frey, Peter F Bousquet, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Novel antibacterial classPeter J Dandliker, Steve D Pratt, Angela M Nilius, et al.
Journal of Medicinal Chemistry|March 9, 2007
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitorYujia Dai, Kresna Hartandi, Zhiqin Ji, et al.
Nature Chemical Biology|January 24, 2017
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrityKenneth D Bromberg, Taylor R H Mitchell, Anup K Upadhyay, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Biomolecular Screening|March 10, 2004
A strategy for discovery of novel broad-spectrum antibacterials using a high-throughput Streptococcus pneumoniae transcription/translation screenSteven D Pratt, Caroline A David, Candace Black-Schaefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2011
Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitorXuesong Liu, Yan Shi, David X Maag, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2012
Thienopyridine ureas as dual inhibitors of the VEGF and Aurora kinase familiesMichael L Curtin, Robin R Frey, H Robin Heyman, et al.
Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Thienopyridine urea inhibitors of KDR kinaseH Robin Heyman, Robin R Frey, Peter F Bousquet, et al.
Antimicrobial Agents and Chemotherapy|November 26, 2003
Novel antibacterial classPeter J Dandliker, Steve D Pratt, Angela M Nilius, et al.
Journal of Medicinal Chemistry|March 9, 2007
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitorYujia Dai, Kresna Hartandi, Zhiqin Ji, et al.
Nature Chemical Biology|January 24, 2017
The SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrityKenneth D Bromberg, Taylor R H Mitchell, Anup K Upadhyay, et al.
Pageof 2